Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04493385 · ClinicalTrials.gov registry record
The Hepatitis C Transplant Collaborative
A clinical trial of Hepatitis C and Transplant; Failure, Heart, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04493385: Recruiting study of Hepatitis C and Transplant; Failure, Heart, sponsored by Baylor Research Institute.
NCT04493385 is a study of Hepatitis C and Transplant; Failure, Heart that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 500 participants, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04493385, a study of Hepatitis C and Transplant; Failure, Heart, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Primary Outcome
To assess the current status of donor HCV NAT+ cardiac transplantation via retrospective data collection.
Conditions Studied
Study Locations (1)
Texas
- Baylor Scott & White Health Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2030-12 |
What NCT04493385 shows while recruiting
NCT04493385 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT04493385 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04493385 about?
NCT04493385 is a clinical study titled "The Hepatitis C Transplant Collaborative". In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
What is the current status of trial NCT04493385?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2019-09-16. Estimated completion is 2030-12.
What conditions does trial NCT04493385 study?
This clinical trial studies the following conditions: Hepatitis C, Transplant; Failure, Heart.
Who is sponsoring clinical trial NCT04493385?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04493385 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04493385's enrollment target sits among peer trials
500 20th of 106 higher than 86 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI